Search Results
Apr 10, 2026, 11:51 ET A Teen Needed a Kidney. A Stranger Watching the News Stepped In
of his dad's kidneys, which they split in half, with Elias keeping the right and Fitzpatrick the left.Fitzpatrick wore a "One Kidney Club" T-shirt, while Elias, now with three kidneys, held kidney-shaped stuffed animals. The two exchanged words, and Elias gave Fitzpatrick a letter he had written. "It
More news about: Hassenfeld Children’s Hospital at NYU Langone
Apr 10, 2026, 11:10 ET Favorable Court Decision for Township of Montclair and BDP Holdings As Redevelopment and PILOT Agreements Approved for Lackawanna Plaza Redevelopment
areas. Wilentz lawyers have practiced at the forefront of landmark cases, regulatory matters and high-profile transactions since its founding by David T. Wilentz in 1919. The firm is based in Woodbridge, New Jersey, with offices in Perth Amboy, Red Bank, New York City, and Philadelphia. For more information,
More news about: Wilentz, Goldman & Spitzer, P.A.
Apr 10, 2026, 10:59 ET NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
induction treatment period of the Phase 2b REZOLVE-AA trial of investigational rezpegaldesleukin, a first-in-class IL-2 pathway agonist and regulatory T-cell (Treg) proliferator." The press release disclosed that the trial failed to reach statistical significance, which Nektar attributed to the inclusion
More news about: Faruqi & Faruqi, LLP
Apr 10, 2026, 10:00 ET PROENERGY Closes Agreement with South Texas Electric Cooperative to Divest Braes Bayou and Brotman Generating Stations
www.proenergyservices.com for more.About STEC South Texas Electric Cooperative, Inc. (STEC) is a pioneering Generation and Transmission (G&T) Cooperative dedicated to delivering reliable and affordable electric power to a diverse membership. Established in 1944, STEC has been at the forefront
More news about: PROENERGY
Apr 10, 2026, 09:31 ET IASO Bio Establishes International Partnership with Instituto Butantan to Develop Innovative Therapy for Hematological Cancer
it has signed a technology licensing agreement with the Instituto Butantan, a leading Brazilian public institution, for the local development of a CAR-T cell therapy for hematological cancer in Brazil. The technology uses the patient's own immune cells to treat the disease. Under the agreement,
More news about: IASO Bio
Apr 10, 2026, 09:23 ET Davos Communications Summit 2026 to Bring Global Leaders to Switzerland to Tackle AI, Trust and Crisis
Newgate, Muck Rack, SRPR, BPRESS, PR Powerhouse, Castle Mount Media, Pinpoint PR, MC Public Affairs, SPRING PR, AIWIZ Digital Marketing, eMedia Monitor, T1A, as well as the American University of Sharjah, the University of Louisiana, the University of Tennessee, and more.The summit's program
More news about: World Communications Forum Association
Apr 10, 2026, 09:19 ET Data Published in Journal of Diabetes Science and Technology from First-in-Human Study Evaluating the Feasibility of Integrated Insulin Delivery and Glucose Monitoring Using an Insulin Patch Pump
designates automated insulin delivery (AID) systems as "the preferred insulin delivery system" for all people with type 1 diabetes (T1D) and intensive insulin-treated type 2 diabetes (T2D). Data show that these systems, which currently comprise an insulin pump, a separate CGM and an algorithm, are more effective
More news about: PharmaSens
Apr 10, 2026, 09:03 ET Segway Powersports to Present Flagship Super Villain SX20T and AT10 W MUD at 139th Canton Fair
operates a global sales and service network with over 1,000 retailers across more than 60 countries and regions.Segway Super Villain SX20T is powered by a 2.0T GDi engine delivering 235 hp and 380 N•m of torque, paired with a 7AT transmission. It reaches speeds up to 150 km/h and handles 70% climbs
More news about: Segway Powersports
Apr 10, 2026, 08:47 ET Swain's Auction House Opens The Foundational Sale -- The Inaugural Live Auction From America's First AI-Powered Platform for Black and African Diaspora Art
swainsauction.com / AUCTIONEER: Naomi T. Lewis, Licensed Benefit Auctioneer / BUYER'S PREMIUM: 15% of hammer price / INQUIRIES: [email protected]
More news about: Swain's
Apr 10, 2026, 08:31 ET OneAZ Credit Union Launches 75th Anniversary Celebration with $750,000 in Legacy Grants to Arizona Nonprofits
support lasting, sustainable impact.Developing Future LeadersBe A Leader Foundation — $75,000NAU Foundation (T. Paul Thomas Center for Nonprofit Entrepreneurship) — $100,000Valle del Sol (Hispanic Leadership Institute) — $225,000Economic Empowerment
More news about: OneAZ Credit Union
Apr 10, 2026, 08:30 ET Quad Issues Temporary Surcharge on Select Printing Products Due to Rising Ink Costs
quad.com.About CR/T Chemical Research/Technology (CR/T) is Quad's ink manufacturing subsidiary. As one of the largest ink manufacturers in the country, it is responsible for the development,
More news about: Quad
Apr 10, 2026, 07:30 ET Leeds Equity Partners Closes Latest Private Equity Fund at $1.9 Billion, Surpassing its Fund Target
the extraordinary partnership we have with our investors, and we are honored by the confidence they have in our team and our strategy," said Jeffrey T. Leeds, Managing Partner of the Firm. "Many of our limited partners have been with us across multiple funds, over the course of decades, and we are delighted
More news about: Leeds Equity Partners
Apr 10, 2026, 07:25 ET DualityBio gibt Annahme des Zulassungsantrags für Trastuzumab Pamirtecan zur Behandlung von nicht resezierbarem oder metastasiertem HER2-positivem Brustkrebs bei erwachsenen Patienten durch die chinesische NMPA bekannt
mehrerer Indikationen von DB-1303/T-Pam in Festlandchina, Hongkong und Macau gemeinsam voranzutreiben. Weltweit werden wir unsere globale strategische Partnerschaft mit BioNTech weiter vertiefen, um die globale Entwicklung dieses Produkts weiter voranzubringen. DB-1303/T-Pam ist ein weltweit gemeinsam entwickeltes
More news about: DualityBio
Apr 10, 2026, 07:23 ET DualityBio annonce l'acceptation par la NMPA chinoise de la demande d'autorisation de mise sur le marché du trastuzumab pamirtecan pour le traitement du cancer du sein HER2 positif non résécable ou métastatique chez l'adulte
commercialisation de multiples indications du DB-1303/T-Pam en Chine continentale, à Hong Kong et à Macao. Au niveau mondial, nous continuerons à renforcer notre partenariat stratégique mondial avec BioNTech afin de poursuivre le développement mondial de ce produit. Le DB-1303/T-Pam est un nouveau médicament co-développé
More news about: DualityBio
Apr 10, 2026, 02:33 ET Terapi CAR-T Pertama di Dunia untuk Tumor Padat Segera Tersedia di Tiongkok
merupakan metode pengobatan CAR-T pertama di dunia yang secara khusus dikembangkan untuk tumor padat dengan target Claudin18.2, biomarker yang biasanya ditemukan pada kanker lambung dan pankreas.Era Baru dalam Pengobatan KankerTerapi CAR-T merupakan metode pengobatan yang
More news about: Jiahui Health
Apr 09, 2026, 23:30 ET Osstem Implant to Strengthen "Growing Together with Customers" Strategy in 2026
accelerating the distribution of its 'Digital Dentistry Solution.' By integrating high-end hardware— such as the MEDIT intraoral scanners and T2 Plus CBCT—with specialized tools like the OneGuide and OneCAS KITs, Osstem is lowering the barriers to implant surgery while maximizing success
More news about: OSSTEM IMPLANT Co., Ltd.
Apr 09, 2026, 23:30 ET Osstem Implant द्वारा 2026 में अपनी "Growing Together with Customers" की रणनीति को मजबूत किया जाएगा
गति दे रहा है। MEDIT इंट्राओरल स्कैनर्स और T2 Plus CBCT जैसे उच्च-स्तरीय हार्डवेयर को OneGuide और OneCAS
More news about: OSSTEM IMPLANT Co., Ltd.
Apr 09, 2026, 20:00 ET Immune Resetting: B-Cell Mediated & Beyond Summit 2026 Oral Presentation: Innovent Biologics Announces Pre-Clinical Results of IBI3055, a Tri-specific T Cell Engager Targeting Autoimmune Diseases
featuring an innovative "1+1+1" T-cell engager design with CD3 masking to minimize non-specific T-cell activation. Preclinical studies show that IBI3055 effectively eliminates CD19- or BCMA-positive cells across a range of expression levels, with activity comparable to mono-targeting T cell engagers. It induces
More news about: Innovent Biologics
Apr 09, 2026, 20:00 ET Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
expertise, the company has built a differentiated portfolio that positions it at the vanguard of the global CAR-T race.OriCell's lead asset, Ori-C101, is a GPC3-targeted autologous CAR-T therapy for advanced hepatocellular carcinoma (HCC). Having successfully navigated investigator-initiated trials
More news about: Oricell Therapeutics Holdings Limited
Apr 09, 2026, 17:41 ET /C O R R E C T I O N -- Gates Industrial Corporation plc/
More news about: Gates Industrial Corporation plc
Apr 09, 2026, 16:30 ET Rowan Digital Infrastructure Announces Strategic Recapitalization
[email protected] T: 971-219-5561QuinbrookRenae McGregor, Head of Marketing and CommunicationsEmail: [email protected]T: +44 7557 386 949BlackstoneClaire
More news about: Rowan Digital Infrastructure